Research Library
CJC-1295 (No DAC) / GHRP-6 research
6 articles to explore, with links to 8 original sources.
About CJC-1295 (No DAC) / GHRP-6
This blend pairs CJC-1295 No DAC with GHRP-6 for laboratory receptor-signaling research.
Understand the science
How structural studies show two different receptor targets
CJC-1295 (No DAC) / GHRP-6 names a modified growth hormone–releasing hormone (GHRH) fragment and a separate synthetic peptide that activates the ghrelin receptor. Structural research helps clarify what it means to give those two signals different receptor targets.
3 sources (2020–2024)
What happened when researchers blocked the body's own releasing signal?
CJC-1295 (No DAC) / GHRP-6 names a modified 29-residue analogue of growth hormone–releasing hormone (GHRH) plus a six-residue peptide that stimulates the ghrelin receptor. Does the growth hormone response to GHRP-6 depend on the body's existing GHRH activity?
2 sources (1998, 2024)
Explore study findings
What a stroke-model experiment tells us about identifying a peptide's partner
CJC-1295 (No DAC) / GHRP-6 pairs the label commonly used for modified growth hormone–releasing factor (1–29) with GHRP-6, a synthetic six-residue agonist of the ghrelin receptor. Can a study pairing GHRP-6 with a different molecule answer questions about this one?
2 sources (2024, 2026)
Why a two-peptide challenge gave different results across groups
CJC-1295 (No DAC) / GHRP-6 combines a label for modified growth hormone–releasing factor (1–29) with GHRP-6, a ghrelin-receptor agonist. What would it take to interpret a response across people with different baseline characteristics?
2 sources (2005, 2024)
Check methods and identity
What a night of sleep measurements adds to an endocrine study
CJC-1295 (No DAC) / GHRP-6 pairs the label commonly used for a synthetic relative of growth hormone–releasing hormone with a six-residue peptide that activates the ghrelin receptor. How can sleep recordings and hormone readings answer different questions about this pathway?
2 sources (1995, 2024)
Interpret the evidence
Distinguishing a GHRP-6 heart study from evidence about the blend
CJC-1295 (No DAC) / GHRP-6 combines a name commonly used for a four-substitution relative of growth hormone–releasing hormone with GHRP-6, a six-residue peptide known to activate the ghrelin receptor.
2 sources (2024, 2026)
